Douglas Elliman, Inc. is an independent residential real estate brokerage firm. It is engaged principally in two business segments: Real Estate Brokerage and Corporate & Other. The Real Estate Brokerage segment consists of residential real estate brokerage services through its subsidiary, Douglas Elliman Realty, which operates a residential brokerage company in the New York metropolitan area and also conducts residential real estate brokerage operations in Florida, California, Connecticut, Massachusetts, Colorado, New Jersey and Texas. The Corporate & Other segment consists of the operations of the holding company as well as its investment business that invests in select PropTech opportunities through its New Valley Ventures subsidiary. The company was founded by Douglas Elliman in 1911 and is headquartered in Miami, FL.

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

LOBO EV Technologies Ltd. engages in the manufacture and sale of electric vehicles. The company designs and develops e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles. It operates through the Electric Vehicles and Accessories Sales, and Software Royalties and Development and Design Services segments. The Electric Vehicles and Accessories Sales segment engages in the manufacture and sale of electric vehicles and accessories. The Software Royalties and Development and Design Services segment provides software solutions development for automotive electronics. The company was founded on October 25, 2021 and is headquartered in Wuxi, China.

Birks Group, Inc. engages in the designing of jewelry, timepieces and gift and operates jewelry stores. It operates through the Retail and Other segments. The Retail segment focuses on stores across Canada under the Maison Birks brand and retail locations in Calgary and Vancouver under Brinkhaus, Graff, and Philippe brands. The Other segment is involved in e-commerce business, wholesale business, and gold exchange program. The company was founded by Henry Birks on March 1, 1879 and is headquartered in Montreal, Canada.

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.